1 – 10 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
(2025) In Cancer immunology research
- Contribution to journal › Article
- 2024
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
- Contribution to journal › Article
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
- Contribution to journal › Article
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
- Contribution to journal › Article
-
Mark
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases : Mariana Reste1† , Kristi Ajazi 2† , Ayca Sayi-Yazgan3,4, Radmila Jankovic 5 , Biljana Bufan6 , Sven Brandau7 , Espen S. Bækkevold 8 , Florent Petitprez 9 , Malin Lindstedt 2 *, Gosse J. Adema10* and Catarina R. Almeida1 *
- Contribution to journal › Article
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
- Contribution to journal › Scientific review
- 2023
-
Mark
A proteomics dataset capturing myeloid cell responses upon cellular exposure to fungicides, adjuvants and fungicide formulations
- Contribution to journal › Article
-
Mark
Upper airway microbiome transplantation for patients with chronic rhinosinusitis
- Contribution to journal › Article
-
Mark
Single-cell analysis of myeloid cells in HPV+ tonsillar cancer
- Contribution to journal › Article
-
Mark
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
- Contribution to journal › Article
